British 8.832995
ĠBi 8.825611
otech 0.7360949
Ġpl 5.667877
c 0.0019408382
's 5.6674733
Ġcancer 6.279202
Ġdrug 0.762051
ĠMar 8.438968
im 2.9850776
ast 0.0055049327
at 0.0062118615
ĠShows 9.678671
ĠPromise 1.0454652
, 5.0223536
ĠBut 2.646215
ĠFaces 3.4330301
ĠH 2.7170978
urd 0.009015867
les 0.040185705
Ġto 4.4600396
ĠBecome 4.3090725
Ġa 0.764403
ĠBlock 3.1768236
buster 0.0036095749
ĠBritish 5.5252814
ĠBi 0.12794966
otech 0.006207483
Ġpl 0.21694559
c 0.0002454927
Ġannounced 4.149781
Ġpromising 3.7043636
Ġresults 0.72635
Ġfor 1.7300069
Ġits 0.35332847
Ġcancer 0.69815487
Ġdrug 0.07404051
, 2.1173534
ĠMar 0.18638457
im 0.00079688436
ast 0.0023615994
at 0.0035829558
, 0.48866627
Ġwhich 1.9525687
Ġtargets 4.512678
Ġthe 1.9259048
Ġfast 7.8480945
- 0.2951
growing 0.05826406
Ġmatrix 10.311562
Ġmet 0.41758513
all 0.01975675
op 0.01711286
rotein 0.07665154
ase 0.76735824
Ġ( 1.1014944
M 0.0077875885
MP 0.0013588498
) 0.38415828
Ġmarket 7.829482
. 0.4316113
ĠThe 1.4697548
Ġdrug 1.5632346
Ġis 1.8121661
Ġdesigned 3.3909461
Ġto 0.08529495
Ġinhibit 1.5422035
Ġthe 1.0258471
Ġactivity 1.3276589
Ġof 0.017525613
Ġspecific 5.010923
ĠM 0.73522574
MP 0.0006901748
s 0.5469439
Ġthat 1.87539
Ġpromote 2.8551314
Ġthe 1.7585851
Ġgrowth 1.3884649
Ġand 1.348149
Ġspread 0.6410382
Ġof 0.012115106
Ġcancer 0.67327833
Ġcells 1.1894664
. 0.35208118
ĠThe 1.626582
Ġdrug 1.9806843
Ġis 1.4958884
Ġcurrently 1.025428
Ġin 0.6141288
ĠPhase 0.6753904
ĠIII 0.8287032
Ġclinical 0.9553876
Ġtrials 0.17414995
, 2.18033
Ġand 0.91112214
Ġresults 3.6271884
Ġfrom 1.0242178
Ġa 1.6858687
Ġrecent 3.453225
Ġtrial 1.5236733
Ġdemonstrate 5.7654862
Ġthe 2.550555
Ġdrug 0.5136104
's 0.54271644
Ġpotential 1.3197898
Ġas 2.0283768
Ġa 0.39857185
Ġtherapeutic 3.5699048
Ġoption 2.18964
Ġfor 0.34422797
Ġcancer 2.4930887
Ġpatients 0.4401017
. 0.1994403
ĠMar 2.413172
im 0.0011796867
ast 0.007414681
at 0.001389231
Ġhas 2.135015
Ġbeen 1.881439
Ġproven 4.3254814
Ġto 0.5530163
Ġbe 1.2850094
Ġeffective 1.3254249
Ġagainst 1.8974545
Ġa 2.0490088
Ġwide 1.650417
Ġrange 0.41593343
Ġof 0.0031513358
Ġcancers 1.0980464
, 0.44945076
Ġincluding 0.2597271
Ġpancreat 3.3769932
ic 0.00025789507
Ġcancer 1.5063013
, 0.18379758
Ġcol 2.0686398
ore 0.001669144
ct 0.00041375431
al 0.00087944814
Ġcancer 0.056389373
, 0.13075717
Ġand 1.1492339
Ġmetast 3.3913467
atic 0.07423
Ġmelan 1.6747881
oma 0.013520906
. 0.21353766
ĠThe 1.4531865
Ġdrug 0.62931836
Ġinhibits 4.413382
Ġthe 0.788856
Ġactivity 0.50823087
Ġof 0.008738941
ĠM 0.9390903
MP 0.00073317625
s 1.5803127
, 1.5835657
Ġwhich 0.4791605
Ġplay 2.705793
Ġcritical 4.3088093
Ġroles 0.018156782
Ġin 0.033073843
Ġmany 4.1245084
Ġphysiological 2.6384847
Ġprocesses 0.3791015
, 0.62273717
Ġsuch 1.8506033
Ġas 0.005231851
Ġtissue 1.6994716
Ġremod 0.9742068
eling 0.041893885
, 0.83963555
Ġwound 1.9930958
Ġhealing 0.21053156
, 0.06370883
Ġand 0.39269733
Ġtumor 1.7394994
Ġinvasion 1.235415
. 0.53879386
ĠWhen 4.26023
ĠM 1.0332097
MP 0.00032026
s 0.23323566
Ġare 0.29447362
Ġover 0.80425155
activated 3.4924276
, 0.30772698
Ġas 3.7185585
Ġin 0.9516192
Ġcancer 0.7507539
, 0.51783276
Ġthey 0.46890435
Ġpromote 1.8079994
Ġthe 0.9760752
Ġgrowth 1.1077496
Ġand 0.30895495
Ġspread 0.124685116
Ġof 0.0029973767
Ġcancer 0.6471466
Ġcells 0.2652284
Ġby 2.4471438
Ġdegrading 1.5338166
Ġthe 0.79280037
Ġext 1.1913226
race 5.0778563e-06
llular 0.00029140117
Ġmatrix 0.020659707
Ġ( 1.9055712
EC 0.06713612
M 0.0005272344
) 1.1176413
Ġsurrounding 2.3976364
Ġthe 1.0010452
Ġtumor 0.5178532
. 0.5976455
ĠThe 2.0167806
ĠPhase 7.9840117
ĠIII 0.14715587
Ġclinical 1.349818
Ġtrial 0.39919963
Ġconducted 4.1425323
Ġby 0.6590511
ĠBritish 0.64315075
ĠBi 0.013434698
otech 0.001093223
Ġpl 2.8115234
c 0.00012882493
Ġdemonstrated 1.8771435
Ġthat 0.5629026
ĠMar 0.5586769
im 0.00051411585
ast 0.0025937979
at 0.0007285281
Ġcan 3.181463
Ġsignificantly 1.6803422
Ġimprove 2.8544557
Ġthe 0.972385
Ġprogression 2.5265152
- 0.084035404
free 0.0031217358
Ġsurvival 0.040667817
Ġrate 2.4166772
Ġof 0.7205471
Ġpatients 0.8701814
Ġwith 0.3636047
Ġadvanced 1.3412411
Ġpancreat 0.8922285
ic 0.00020453747
Ġcancer 0.06737429
. 0.576046
ĠIn 2.1504092
Ġthe 1.1706586
Ġtrial 0.7373541
, 0.01858764
Ġpatients 1.5230774
Ġwho 1.9083302
Ġreceived 0.50149524
ĠMar 0.4453581
im 0.00092198397
ast 0.0011815969
at 0.0008493221
Ġhad 2.210713
Ġa 0.33607605
Ġmedian 1.0496807
Ġprogression 0.23570469
- 0.022161545
free 0.0015803694
Ġsurvival 0.010150053
Ġrate 1.1678933
Ġof 0.038562108
Ġ2 4.2467504
. 0.023722269
3 2.4174604
Ġmonths 0.047536768
, 0.28011745
Ġcompared 0.59699106
Ġto 0.26261902
Ġ1 1.204925
. 0.030199364
6 2.501767
Ġmonths 0.009270189
Ġfor 0.36929724
Ġpatients 0.52490443
Ġwho 0.31653494
Ġreceived 0.26037434
Ġthe 1.4168577
Ġplacebo 0.9739584
. 0.119228475
ĠThe 1.2311125
Ġdrug 1.8751345
Ġshowed 3.8472424
Ġsimilar 1.5522805
Ġpromising 3.3473423
Ġresults 0.110306814
Ġin 0.58646303
Ġthe 1.7114652
Ġtreatment 0.84073955
Ġof 0.004558302
Ġother 2.5943515
Ġcancers 1.1286614
Ġas 2.2586262
Ġwell 0.0037577634
. 0.36453977
ĠHowever 4.876699
, 0.0018924067
Ġdespite 2.7086234
ĠMar 1.7666303
im 0.0012769628
ast 0.0018431388
at 0.0020782624
's 0.037874285
Ġpotential 1.7070324
Ġto 1.9674183
Ġbecome 0.5280867
Ġa 0.05982768
Ġblockbuster 0.186128
Ġdrug 0.94462407
, 0.18177374
Ġthere 2.0918787
Ġare 0.090249054
Ġsignificant 2.4717731
Ġhurdles 1.0017905
Ġthat 1.1509411
ĠBritish 2.1226707
ĠBi 0.0056482432
otech 0.0006817035
Ġpl 0.13406372
c 0.00025097816
Ġwill 1.118524
Ġhave 0.63811094
Ġto 0.0013331261
Ġovercome 0.11649514
. 1.9301307
ĠFirstly 4.640316
, 0.0020911049
Ġthe 0.81995326
Ġdrug 0.78157544
's 2.1517487
Ġpatent 2.9672928
Ġprotection 1.0992681
Ġhas 2.3172345
Ġexpired 0.42360726
, 0.58712494
Ġwhich 1.158438
Ġmeans 0.97384495
Ġthat 0.3179467
Ġthe 2.054836
Ġdrug 0.852717
Ġis 1.488959
Ġnow 1.7786078
Ġavailable 1.3099701
Ġas 1.5862763
Ġa 0.11575292
Ġgeneric 0.17414293
Ġdrug 1.4189149
. 0.67507786
ĠThis 1.8398004
Ġwill 1.5068781
Ġmake 2.3343844
Ġit 0.27411428
Ġdifficult 0.7270066
Ġfor 0.1207672
ĠBritish 0.7471177
ĠBi 0.010437128
otech 6.325358e-05
Ġpl 0.17596641
c 0.00023261909
Ġto 0.018967958
Ġgenerate 2.034034
Ġsignificant 1.1934248
Ġrevenue 0.76757807
Ġfrom 0.33614635
Ġthe 0.6418136
Ġdrug 0.17863828
. 0.5850994
ĠSecondly 1.2046319
, 0.001173839
Ġthe 0.8479622
Ġcompany 1.7317761
Ġwill 1.5284723
Ġneed 1.8004161
Ġto 0.018356126
Ġdemonstrate 3.4245906
Ġthe 1.0629154
Ġdrug 0.44624966
's 0.011608149
Ġsafety 1.553641
Ġand 0.36839417
Ġefficacy 0.39093393
Ġthrough 3.7434275
Ġfurther 2.5144904
Ġclinical 0.22581701
Ġtrials 0.08423511
. 0.70880604
ĠWhile 4.7303476
Ġthe 1.0181965
Ġresults 2.1447217
Ġfrom 0.6974406
Ġthe 0.29017755
ĠPhase 0.37121788
ĠIII 0.0322399
Ġclinical 0.8303355
Ġtrial 0.14180438
Ġare 1.1904825
Ġpromising 0.5398068
, 0.014135226
Ġthey 2.0083146
Ġwill 2.8821921
Ġneed 0.47427058
Ġto 0.018777052
Ġbe 0.01923254
Ġreplicated 1.2743089
Ġin 0.47054598
Ġlarger 2.204919
- 2.690276
scale 0.010321494
Ġtrials 0.7877174
Ġto 2.0340848
Ġensure 1.8664244
Ġthat 1.1100593
Ġthe 0.29891866
Ġdrug 0.17892529
Ġis 0.4780611
Ġsafe 0.4332457
Ġand 0.4348016
Ġeffective 0.076386
Ġfor 1.4220161
Ġa 2.2022624
Ġwider 1.6261349
Ġrange 0.46595478
Ġof 0.001084271
Ġpatients 0.78736645
. 0.08135763
ĠThird 2.4951673
ly 0.02809742
, 0.0022513126
ĠMar 2.48346
im 0.0013688764
ast 0.0016881911
at 0.00069888175
Ġfaces 3.1192245
Ġcompetition 0.7082175
Ġfrom 0.087693
Ġother 0.80422175
ĠM 1.3730935
MP 0.00035132372
Ġinhibitors 0.21259733
Ġcurrently 3.2684994
Ġin 0.44369805
Ġdevelopment 0.97846293
. 0.50398004
ĠSeveral 4.379484
Ġother 1.9991717
Ġpharmaceutical 2.908809
Ġcompanies 0.09926117
Ġare 0.62281865
Ġdeveloping 0.71850884
ĠM 0.92169094
MP 0.00018307802
Ġinhibitors 0.08932336
Ġto 2.0195878
Ġtarget 2.4399185
Ġcancer 1.9439107
, 1.296773
Ġsuch 1.9600246
Ġas 0.0031340541
ĠGl 5.1007166
ax 0.021586804
o 0.0076379054
Smith 0.004855159
K 0.0065328465
line 0.0026343765
Ġpl 0.42473957
c 9.520714e-05
's 1.5379136
ĠB 4.5967746
MS 2.1294558
- 0.042008314
275 1.7591134
291 0.4207844
Ġand 1.0699457
ĠMillennium 6.0800996
ĠPharmaceutical 0.13625416
s 0.043132532
ĠInc 0.57089037
.' 0.22989224
s 0.0025046412
Ġ( 2.978113
now 4.993328
ĠT 1.2241623
aked 0.008770809
a 0.00034726874
ĠPharmaceutical 0.065759994
ĠCo 0.8045521
. 0.6860983
ĠLtd 0.015923705
.) 0.45323294
ĠPrin 11.487584
om 0.058108207
ast 0.022375956
at 0.002117984
. 0.13472135
ĠThis 4.549259
Ġmeans 2.4584186
Ġthat 0.053955533
ĠBritish 0.5013061
ĠBi 0.00905887
otech 0.0006711474
Ġpl 0.0335362
c 0.00021049884
Ġwill 0.27173293
Ġneed 1.2318126
Ġto 0.011408212
Ġwork 3.3261366
Ġhard 0.7419485
Ġto 0.070949316
Ġdifferentiate 2.0298445
ĠMar 1.0414234
im 0.00036169955
ast 0.0012521946
at 0.00043581732
Ġfrom 0.25290766
Ġits 0.8823995
Ġcompetitors 0.17587467
Ġand 2.4302063
Ġposition 4.6476383
Ġit 1.4059759
Ġas 0.14327888
Ġthe 0.8746256
Ġmost 1.8376578
Ġeffective 0.4399261
ĠM 1.3254153
MP 0.00016447584
Ġinhibitor 0.025768233
. 0.9983312
ĠBritish 1.9342686
ĠBi 0.0074399626
otech 0.0012097067
Ġpl 0.07316094
c 0.00023667031
Ġwill 2.1729023
Ġneed 1.4610716
Ġto 0.03259847
Ġinvest 4.222883
Ġin 1.6976966
Ġmarketing 2.7742307
Ġand 0.6434376
Ġresearch 4.023828
Ġand 0.4158938
Ġdevelopment 0.0030844281
Ġto 0.83109283
Ġensure 1.4653045
Ġthat 0.3235804
ĠMar 1.1137153
im 0.0004636042
ast 0.0010213233
at 0.00032550612
Ġbecomes 2.0876703
Ġa 0.18710767
Ġblockbuster 0.7436737
Ġdrug 0.1528073
. 0.2310051
ĠThe 2.200721
Ġcompany 0.28332803
Ġwill 1.060547
Ġneed 1.2593784
Ġto 0.018983994
Ġconduct 2.3372762
Ġfurther 1.1408648
Ġtrials 2.7108462
Ġto 0.40350768
Ġdemonstrate 1.0518879
Ġthe 0.20709135
Ġdrug 0.14803904
's 0.0019056023
Ġsafety 0.3433543
Ġand 0.07760828
Ġefficacy 0.10519569
Ġand 2.4632435
Ġto 1.6628017
Ġdetermine 3.7714238
Ġthe 0.6188229
Ġoptimal 1.643901
Ġdose 1.4079431
Ġand 1.5972149
Ġtreatment 1.388506
Ġfor 6.0940223
Ġeach 2.564276
Ġcancer 1.1574407
Ġtype 0.57724565
. 0.103550225
ĠAdditionally 3.5382762
, 0.0018483935
Ġthe 0.6006836
Ġcompany 0.04353824
Ġwill 0.19564126
Ġneed 0.20780484
Ġto 0.00560203
Ġdevelop 2.6013231
Ġstrong 4.36022
Ġpartnerships 2.0199835
Ġwith 0.28774127
Ġphysicians 3.5525734
, 1.8720798
Ġhospitals 1.735908
, 0.10128911
Ġand 0.092071705
Ġother 1.8790597
Ġstakeholders 2.8625708
Ġto 0.45168975
Ġensure 1.1265159
Ġthat 0.25262547
ĠMar 0.9526758
im 0.00041745167
ast 0.0022158881
at 0.00046479818
Ġis 0.6398571
Ġwidely 1.9900274
Ġprescribed 2.0228634
Ġand 1.9646715
Ġused 0.9042182
Ġin 1.6834962
Ġthe 1.3101982
Ġtreatment 0.40234402
Ġof 0.008390863
Ġcancer 0.37322292
. 0.4654797
ĠDespite 3.442396
Ġthe 0.394262
Ġchallenges 1.0973762
, 1.293474
ĠMar 0.8269162
im 0.00050791225
ast 0.001207438
at 0.00035657262
's 1.8825954
Ġpotential 1.2462268
Ġto 0.91723216
Ġbecome 0.25793436
Ġa 0.036330428
Ġblockbuster 0.079467796
Ġdrug 0.101869054
Ġis 1.2020528
Ġsignificant 2.258903
. 0.43727624
ĠThe 1.0504204
Ġdrug 0.33499
Ġhas 1.1828794
Ġdemonstrated 2.1126592
Ġpromising 1.7731434
Ġresults 0.13131912
Ġin 0.26744264
ĠPhase 1.8964967
ĠIII 0.041477904
Ġclinical 0.1633811
Ġtrials 0.013928798
Ġand 1.5086205
Ġhas 1.0752745
Ġthe 1.300583
Ġpotential 0.037188105
Ġto 0.00874267
Ġbecome 1.280678
Ġa 0.47894725
Ġvaluable 3.863952
Ġtherapeutic 0.8299554
Ġoption 0.09658847
Ġfor 0.12953891
Ġcancer 0.407145
Ġpatients 0.018187372
. 0.11787882
ĠBritish 1.3069826
ĠBi 0.0051885894
otech 0.00082074676
Ġpl 0.031835612
c 0.00010021203
Ġmust 5.2939396
Ġwork 1.7159264
Ġhard 0.23982543
Ġto 0.045245115
Ġovercome 1.1749588
Ġthe 0.15725733
Ġhurdles 1.298053
Ġand 1.7959946
Ġposition 2.154265
ĠMar 0.7914714
im 0.00034929716
ast 0.0007854929
at 0.00021431445
Ġas 0.10977245
Ġthe 0.68594426
Ġmost 1.106624
Ġeffective 0.11954301
ĠM 0.3062911
MP 0.0001758016
Ġinhibitor 0.011859693
Ġon 2.2988067
Ġthe 0.0011414367
Ġmarket 0.008212782
. 0.14562047
ĠWith 4.67402
Ġthe 1.1353911
Ġright 1.1802989
Ġinvestment 3.423152
Ġand 0.6451091
Ġstrategy 3.3064969
, 0.050368313
ĠMar 1.0314598
im 0.00038722056
ast 0.00094877306
at 0.00038865104
Ġcould 0.76819956
Ġbecome 0.5242999
Ġa 0.24150686
Ġkey 4.5314302
Ġplayer 2.6494339
Ġin 0.032422923
Ġthe 0.116726205
Ġfight 3.1176267
Ġagainst 0.017101277
Ġcancer 0.040364232
. 0.2637816
